Identification of ligands selective for central I2-imidazoline binding sites

Neurochemistry International

Volumn 30, Issue 1, 1997, Pages 47-53

  Hudson, A L ^a   Chapleo, C B ^b   Lewis, J W ^c   Husbands, S ^c   Grivas, K ^d   Mallard, N J ^d   Nutt, D J ^d  

^a SCHOOL OF MEDICAL SCIENCES   (United Kingdom)

^b Reckitt & Colman   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; IDAZOXAN; IMIDAZOLINE I2 RECEPTOR; LIGAND; RADIOLIGAND;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; BRAIN MEMBRANE; CHEMICAL STRUCTURE; CONTROLLED STUDY; FEMALE; LIGAND BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BENZOFURANS; BRAIN; CELL MEMBRANE; FEMALE; IDAZOXAN; LIGANDS; MALE; RABBITS; RADIOLIGAND ASSAY; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, DRUG; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031018719     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(96)00037-X     Document Type: Article

References (37)

1. Atlas, D., Diamant, S. and Zonnenschein, R. (1991). Imidazoline receptors and the endogenous clonidine displacing substance (CDS). In Adrenoceptors: Structure, Mechanisms, Function (Szabadi, E. and Bradshaw, C.M., Eds), pp. 91-100. Birkhäuser Verlag, Basel.
2. Bradford, M. M. (1976) A rapid sensitive method for the quantification of protein using the principle of protein dye binding. Anal. Biochem. 72, 248-252.
3. Bricca, G., Greney, H., Zhang, J., Dontenwill, M., Stutzmann, J., Belcourt, A. and Bousquet, P. (1994) Eur. J. Pharmacol. 266, 25-33.
4. Carpéné, C., Collon, P., Remaury, A., Cordi, A., Hudson, A. and Lafontan, M. (1995) Inhibition of amine oxidase activity by derivatives recognising non-adrenergic imidazoline binding sites (NAIBS). J. Pharmacol. Exper. Ther. 272, 681-688.
5. 2-adrenoceptor antagonist efaroxan is mediated by a novel, stereoselective, binding site. Eur. J. Pharmacol. 230, 375-378.
6. Chapleo, C. B. (1986). The discovery of idazoxan. Chemistry in Britain. April, pp. 313-314.
7. Chapleo, C. B., Myers, P. L., Butler, R. C. M., Doxey, J. C., Roach, A. G. and Smith, C. F. C. (1983) Alpha-adrenoceptor reagents. 1. Synthesis of some 1,4-benzodioxans as selective presynaptic alpha-2-adrenoceptor antagonists and potential antidepressants. J. Med. Chem. 26, 823-831.
8. Chapleo, C. B., Myers, P. L., Butler, R. C. M., Davis, J. A., Doxey, J. C., Higgins, S. D., Myers, M., Roach, A. G., Smith, C. F. C., Stillings, M. R. and Welbourn, A. P. (1984) α-Adrenoceptor reagents. 2. Effects of modification of the 1,4-benzodioxan ring system on α-adrenoceptor activity. J. Med. Chem. 27, 570-576.
9. 50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108.
10. Diamant, S., Eldar-geva, T. and Atlas, D. (1992) Imidazoline binding sites in human placenta: evidence for heterogeneity and a search for physiological function. Br. J. Pharmacol. 106, 101-108.
11. 2 subtypes. Fund. Clin. Pharmacol. 6(1), P18.
12. 1-imidazoline receptors. J. Cardiovas. Pharmacol. 20, S1-S10.
13. Feldman, J., Tibirica, E., Bricca, G., Dontenwill, M., Belcourt, A. and Bousquet, P. (1990) Evidence for the involvement of imidazoline receptors in the hypotensive effect of rilmenidine in the rabbit. Br. J. Pharmacol. 100, 600-604.
14. Ghika, J., Tennis, M., Hoffma, E., Schoenfeld, D. and Growden, J. (1991) Idazoxan treatment in progressive supranuclear palsy. Neurology 41, 986-991.
15. Gomez, R., Ernsberger, P., Feinland, G. and Reis, D. J. (1991) Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area. Eur. J. Pharmacol. 195, 181-191.
16. 2-adrenoceptors in the rat brain. Mol. Neuropharmacol. 1, 219-229.
17. Hudson, A. L., Mallard, N., Nutt, D. and Chapleo, C. (1992) RX821029: a selective ligand for non-adrenoceptor idazoxan binding sites in mammalian brain. Fundam. Clin. Pharmacol. 6(1:45s), 14.
18. 2-sites). Br. J. Pharmacol. 114, 411P.
19. 3H]-idazoxan. Fund. Clin. Pharmacol. 6(1), P13.
20. Ivkovic, B., Bakthavachalam, V., Neumeyer, J., Lanier, S., Brasili, L. and Pigini, M. (1992) Cirazoline derivatives as molecular probes for the imidazoline-guanidinium receptive site (IGRS). Fund. Clin. Pharmacol. 6(1:II), 11.
21. Ivkovic, B., Bakthavachalam, V., Zhang, W., Parini, A., Diz, D., Bosch, S., Neumayer, J. L. and Lanier, S. M. (1994) Development of a high-affinity radioiodinated ligand for identification of imidazoline/guanidinium receptive sites (IGRS): Intratissue distribution of IGRS in liver, forebrain and kidney. Molecular Pharmacol. 46, 15-23.
22. Jackson, H. C., Ripley, T. L., Dickinson, S. L. and Nutt, D. J. (1991) Anticonvulsant activity of the imidazoline 6.7-benzoidazoxan. Epilepsy. Res. 9, 121-126.
23. Lalies, M. D. and Nutt, D. J. (1993) A microdialysis study of the neurochemical effects in rat striatum of RX821029, a selective ligand for non-adrenoceptor binding sites. Br. J. Pharmacol. 109, 85P.
24. 2-site ligand, 2-(2-benzofuranyl)-2-imidazoline, in in vivo noradrenaline release in rat brain. Br. J. Pharmacol. 114, 413P.
25. Lanier, S. M., Ivkovic, B., Singh, I., Neumeyer, J. L. and Bakthavachalam V. (1993) Visualisation of multiple imidazoline/guanidinium-receptive sites. J. Biochem. Mol. Biol. 265, 16047-16051.
26. 2-sites). Br. J. Pharmacol. 114, 412P.
27. 3H]2-(2-benzofuranyl)-2-imidazoline in rat brain. Br. J. Pharmacol. 116, 338P.
28. 2 imidazoline receptors. Br. J. Pharmacol. 116, 1729-1736.
29. Mallard, N. J., Hudson, A. L. and Nutt, D. J. (1992) Characterisation and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain. Br. J. Pharmacol. 106, 1019-1027.
30. Michel, M. C. and Insel, P. A. (1989) Are there multiple imidazoline binding sites?. Trends. Pharmacol. Sci. 10, 342-344.
31. Nutt, D. J., French, N., Handley, S., Hudson, A., Husbands, S., Jackson, H., Jordan, S., Lalies, M.D., Lewis, J., Lione, L., Mallard, N. and Pratt, J. (in press). Functional studies of specific imidazoline-2 receptor ligands. Annals. New. York. Acad. Sci. Proceedings of II International Symposium on Imidazoline Receptors.
32. 3H]-idazoxan binding sites in the rat brain. Br. J. Pharmacol. 108, 597-603.
33. Osman, O. T., Rudorfer, M. V. and Potter, W. Z. (1986) Idazoxan: A selective alpha2:alpha1-antagonist and effective sustained antidepressant in two bipolar depressed patients. Arch. Gen. Psychiatr. 46, 958-959.
34. 2-type receptors: pharmacological characterisation and relationship to monoamine oxidase. Br. J. Pharmacol. 109, 625-631.
35. 2 with monoamine oxidase-B sites. J. Neurochem. 61, 881-889.
36. 2-adrenoceptors and non-adrenergic idazoxan binding sites in rabbit colon epithelial cells. Eur. J. Pharmacol. 191, 59-68.
37. 2-adrenoceptor antagonists. J. Med. Chem. 27, 570-576.